FDA
-
-
-
-
-
-
-
UBS Starts Kodiak Sciences Inc. (KOD) at Buy
-
-
-
-
-
-
-
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Kodiak Sciences Announces Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Kodiak Sciences Completes Enrollment in GLEAM and GLIMMER Phase 3 Clinical Trials of KSI-301 in Patients with Diabetic Macular Edema
-
-
-
-
-
-
-
Kodiak Sciences Announces Third Quarter 2020 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
UPDATE: Goldman Sachs Starts Kodiak Sciences Inc. (KOD) at Buy
-
-
329,912 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

